Xie Y, Xiao D, Li D, Peng M, Peng W, Duan H
Front Oncol. 2024; 14:1441222.
PMID: 39156700
PMC: 11327142.
DOI: 10.3389/fonc.2024.1441222.
Sahu R, Tandon S, Singh S, Das B, Hedau S
BMC Cancer. 2024; 24(1):566.
PMID: 38711004
PMC: 11071212.
DOI: 10.1186/s12885-024-12274-x.
Nie C, Zhou X, Zhou J, Liu Z, Gu Y, Liu W
EMBO J. 2023; 42(15):e111951.
PMID: 37334492
PMC: 10390875.
DOI: 10.15252/embj.2022111951.
Kang Y
Clin Transl Oncol. 2023; 25(7):1869-1892.
PMID: 37067729
PMC: 10250522.
DOI: 10.1007/s12094-023-03189-3.
Wu X, Guo M, Cui J, Cai H, Wang S
Oncogenesis. 2022; 11(1):41.
PMID: 35869059
PMC: 9307611.
DOI: 10.1038/s41389-022-00417-3.
The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis.
Lin K, Baritaki S, Vivarelli S, Falzone L, Scalisi A, Libra M
Antioxidants (Basel). 2022; 11(6).
PMID: 35740092
PMC: 9227079.
DOI: 10.3390/antiox11061195.
Health influenced by genetics: A first comprehensive analysis of breast cancer high and moderate penetrance susceptibility genes in the Tunisian population.
Boujemaa M, Mighri N, Chouchane L, Boubaker M, Abdelhak S, Boussen H
PLoS One. 2022; 17(3):e0265638.
PMID: 35333900
PMC: 8956157.
DOI: 10.1371/journal.pone.0265638.
Metabolomic Identification of Anticancer Metabolites of Australian Propolis and Proteomic Elucidation of Its Synergistic Mechanisms with Doxorubicin in the MCF7 Cells.
Alsherbiny M, Bhuyan D, Radwan I, Chang D, Li C
Int J Mol Sci. 2021; 22(15).
PMID: 34360606
PMC: 8346082.
DOI: 10.3390/ijms22157840.
Cavin3 released from caveolae interacts with BRCA1 to regulate the cellular stress response.
McMahon K, Stroud D, Gambin Y, Tillu V, Bastiani M, Sierecki E
Elife. 2021; 10.
PMID: 34142659
PMC: 8279762.
DOI: 10.7554/eLife.61407.
A genetic variant in microRNA-146a is associated with sporadic breast cancer in a Southern Brazilian Population.
Brincas H, Augusto D, Mathias C, Cavalli I, Lima R, Kuroda F
Genet Mol Biol. 2020; 42(4):e20190278.
PMID: 32142098
PMC: 7198002.
DOI: 10.1590/1678-4685-GMB-2019-0278.
Oxidative DNA Damage Modulates DNA Methylation Pattern in Human Breast Cancer 1 (BRCA1) Gene via the Crosstalk between DNA Polymerase β and a DNA Methyltransferase.
Jiang Z, Lai Y, Beaver J, Tsegay P, Zhao M, Horton J
Cells. 2020; 9(1).
PMID: 31963223
PMC: 7016758.
DOI: 10.3390/cells9010225.
ZC3H18 specifically binds and activates the BRCA1 promoter to facilitate homologous recombination in ovarian cancer.
Kanakkanthara A, Huntoon C, Hou X, Zhang M, Heinzen E, OBrien D
Nat Commun. 2019; 10(1):4632.
PMID: 31604914
PMC: 6789141.
DOI: 10.1038/s41467-019-12610-x.
The effects of BRCA1 expression on the chemosensitivity of gastric cancer cells to platinum agents.
Kim G, Kim J, Han S, Hwang I, Kim H, Min H
Oncol Lett. 2019; 17(6):5023-5029.
PMID: 31186713
PMC: 6507359.
DOI: 10.3892/ol.2019.10169.
Precise tuning of gene expression levels in mammalian cells.
Michaels Y, Barnkob M, Barbosa H, Baeumler T, Thompson M, Andre V
Nat Commun. 2019; 10(1):818.
PMID: 30778069
PMC: 6379387.
DOI: 10.1038/s41467-019-08777-y.
How latent viruses cause breast cancer: An explanation based on the microcompetition model.
Polansky H, Schwab H
Bosn J Basic Med Sci. 2018; 19(3):221-226.
PMID: 30579323
PMC: 6716096.
DOI: 10.17305/bjbms.2018.3950.
BRCA1 Promoter Methylation and Clinicopathological Characteristics in Sporadic Breast Cancer Patients in Indonesia.
Harahap W, Sudji I, Nindrea R
Asian Pac J Cancer Prev. 2018; 19(9):2643-2649.
PMID: 30256562
PMC: 6249447.
DOI: 10.22034/APJCP.2018.19.9.2643.
BRCA1 and BRCA2 5' noncoding region variants identified in breast cancer patients alter promoter activity and protein binding.
Burke L, Sevcik J, Gambino G, Tudini E, Mucaki E, Shirley B
Hum Mutat. 2018; 39(12):2025-2039.
PMID: 30204945
PMC: 6282814.
DOI: 10.1002/humu.23652.
The potential role of miRNAs in therapy of breast and ovarian cancers associated with BRCA1 mutation.
Strumidlo A, Skiba S, Scott R, Lubinski J
Hered Cancer Clin Pract. 2017; 15:15.
PMID: 29021870
PMC: 5622493.
DOI: 10.1186/s13053-017-0076-7.
Effect of TPA and HTLV-1 Tax on BRCA1 and ERE controlled genes expression.
Jabareen A, Abu-Jaafar A, Abou-Kandil A, Huleihel M
Cell Cycle. 2017; 16(14):1336-1344.
PMID: 28594273
PMC: 5539818.
DOI: 10.1080/15384101.2017.1327491.
Taking a Bad Turn: Compromised DNA Damage Response in Leukemia.
Nilles N, Fahrenkrog B
Cells. 2017; 6(2).
PMID: 28471392
PMC: 5492015.
DOI: 10.3390/cells6020011.